Schonfeld Strategic Advisors’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Schonfeld Strategic Advisors’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-30,000	Closed	-$3K	–	2582
2024 Q4	$3K	Hold	30,000	–	–	﹤0.01%	1924
2024 Q3	$2.12K	Hold	30,000	–	–	﹤0.01%	1947
2024 Q2	$2.96K	Hold	30,000	–	–	﹤0.01%	2041
2024 Q1	$4.2K	Buy	30,000 +5,000	+20%	+$568	﹤0.01%	1942
2023 Q4	$2.02K	Buy	+25,000	New	+$3.37K	﹤0.01%	1735

Other funds holding NKGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return

Schonfeld Strategic Advisors's NKGNW Position: Q1 2025 in Review

Schonfeld Strategic Advisors sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q1 2025, closing a stake of 30,000 shares — an estimated $3K sold.

Schonfeld Strategic Advisors first reported a position in NKGNW in Q4 2023 and held it in 5 quarters. The position peaked at $4.2K in Q1 2024. 3 funds tracked by Wall St. Rank hold NKGNW as of Q1 2025.

Schonfeld Strategic Advisors reported no remaining NKGen Biotech, Inc. Warrants position as of Q1 2025 after selling out during the quarter.
Schonfeld Strategic Advisors sold 30,000 NKGen Biotech, Inc. Warrants shares in Q1 2025, an estimated $3K.
Schonfeld Strategic Advisors first reported a position in NKGen Biotech, Inc. Warrants in Q4 2023 and held it in 5 quarters.
Schonfeld Strategic Advisors's NKGen Biotech, Inc. Warrants position peaked at $4.2K in Q1 2024.
3 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q1 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2025, filed 15 May 2025.